📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling. (2021)

First Author: Bolado-Carrancio A
Attributed to:  Precision medicine and the mutational landscape of high grade serous ovarian cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41388-021-02017-8

PubMed Identifier: 34556814

Publication URI: http://europepmc.org/abstract/MED/34556814

Type: Journal Article/Review

Volume: 40

Parent Publication: Oncogene

Issue: 44

ISSN: 0950-9232